Elsevier

Biochemical Pharmacology

Volume 47, Issue 7, 29 March 1994, Pages 1253-1257
Biochemical Pharmacology

Short communication
Characterization of the enzyme responsible for the metabolism of sumatriptan in human liver

https://doi.org/10.1016/0006-2952(94)90397-2Get rights and content

Abstract

Studies have been undertaken to investigate the enzymes responsible for the metabolism of [14C]sumatriptan in man. Oxidative deamination of sumatriptan to form the indole acetic acid derivative is the only phase 1 pathway evident in man and both cytochrome P450 (P450) and monoamine oxidase (MAO) are capable of catalysing this type of reaction. The metabolism of [14C]sumatriptan was therefore investigated in vitro in a preparation derived from human liver, which was shown, by the use of the probe substrates [14C]testosterone (P450), [3H]5HT (MAO-A) and [14C]benzylamine (MAO-B) to be a rich source of both enzyme systems. Incubation with clorgyline and deprenyl, probe inhibitors of MAO-A and MAO-B, respectively, showed that [14C]sumatriptan was metabolized by MAO-A; there was no evidence of P450 involvement in its metabolism. The data in this study therefore indicate that the enzyme MAO-A is the major enzyme responsible for the metabolism of sumatriptan in human liver.

References (13)

There are more references available in the full text version of this article.

Cited by (0)

View full text